Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Epstein

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Haematology|December 12, 2007
The Arkansas approach to therapy of patients with multiple myelomaBart Barlogie, Elias Anaissie, Frits van Rhee, et al.
Blood|February 29, 2008
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaYa-Wei Qiang, Yu Chen, Owen Stephens, et al.
British Journal of Haematology|November 17, 2015
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3Stephen W Erickson, Owen W Stephens, Shweta S Chavan, et al.
Blood|July 2, 2002
Soluble syndecan-1 promotes growth of myeloma tumors in vivoYang Yang, Shmuel Yaccoby, Wei Liu, et al.
Oncotarget|June 21, 2014
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisXenofon Papanikolaou, Sarah Johnson, Tarun Garg, et al.
BMC Bioinformatics|July 20, 2005
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)Huixiao Hong, Yvonne Dragan, Joshua Epstein, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Experimental Hematology|February 26, 2013
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activitySathisha Upparahalli Venkateshaiah, Sharmin Khan, Wen Ling, et al.
BMC Cancer|July 8, 2018
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myelomaYa-Wei Qiang, Shiqiao Ye, Yuhua Huang, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Haematology|December 12, 2007
The Arkansas approach to therapy of patients with multiple myelomaBart Barlogie, Elias Anaissie, Frits van Rhee, et al.
Blood|February 29, 2008
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaYa-Wei Qiang, Yu Chen, Owen Stephens, et al.
British Journal of Haematology|November 17, 2015
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3Stephen W Erickson, Owen W Stephens, Shweta S Chavan, et al.
Blood|July 2, 2002
Soluble syndecan-1 promotes growth of myeloma tumors in vivoYang Yang, Shmuel Yaccoby, Wei Liu, et al.
Oncotarget|June 21, 2014
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisXenofon Papanikolaou, Sarah Johnson, Tarun Garg, et al.
BMC Bioinformatics|July 20, 2005
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)Huixiao Hong, Yvonne Dragan, Joshua Epstein, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Experimental Hematology|February 26, 2013
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activitySathisha Upparahalli Venkateshaiah, Sharmin Khan, Wen Ling, et al.
BMC Cancer|July 8, 2018
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myelomaYa-Wei Qiang, Shiqiao Ye, Yuhua Huang, et al.
Pageof 9